HIGHLIGHTS
- who: Antonio Vitale et al. from the Uveitis Center, Rheumatology Unit, Department of Medical Sciences, Surgery and Neurosciences, University of Siena, Siena, Italy have published the Article: Real-Life Data on the Efficacy of Canakinumab in Patients with Adult-Onset Still ’ s Disease, in the Journal: Mediators of Inflammation 9 8 Number of patients of 15/Oct/2020
- what: The aim of the study was to assess the clinical and laboratory effect of CAN in controlling AOSD activity.
- how: The authors conducted the present retrospective study to evaluate the role of CAN as . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.